Fri.Dec 16, 2022

article thumbnail

Best of the Best: Nho Nguyen, PharmD, on Helping Patients in Adverse Conditions

Drug Topics

Winner of SingleCare's Best of the Best: Best Pharmacist, Nguyen joined Drug Topics® to discuss how he's helped patients during adverse conditions and what makes for a successful patient encounter.

183
183
article thumbnail

Investigators Identify Compound That May Halt Infections, Including Common Cold, COVID-19

Pharmacy Times

Findings from the University of British Columbia’s Life Sciences Institute show a potential path toward antiviral treatments that could be used against many different pathogens.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

CSL closes on EU approval for haemophilia B gene therapy

pharmaphorum

CSL’s gene therapy for haemophilia B has been recommended for approval by the EMA’s human medicine committee, setting up a decision by the European Commission early next year. The positive opinion for etranacogene dezaparvovec – which was approved as Hemgenix by the FDA last month – raises the prospect of the first one-time therapy in the EU for the bleeding disorder, which affects around 1 in 50,000 of the population, according to the European Haemophilia Network (EUHANET).

FDA 126
article thumbnail

Study Finds SARS-CoV-2 Booster Vaccination Lowers Infections, Hospitalizations, and Deaths in Nursing Homes

Pharmacy Times

There are limited data on the efficacy of boosters for preventing infection and death in nursing home residents, but the findings suggest that boosters may have significantly reduced COVID-19–associated morbidity and mortality in this population.

article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

2023 forecast: Health tech tools begin constructing the Alzheimer's treatment plan

Fierce Healthcare

2023 forecast: Health tech tools begin constructing the Alzheimer's treatment plan. aburky. Fri, 12/16/2022 - 17:17.

142
142
article thumbnail

Study Identifies Barriers to PrEP Uptake in Black Female Adolescents, Young Adults

Pharmacy Times

Study findings provide insight into factors preventing the uptake of pre-exposure prophylaxis for HIV among Black female adolescents and emerging adults and provide potential strategies to improve uptake.

123
123

More Trending

article thumbnail

FDA Approves Adalimumab Biosimilar for Plaque Psoriasis, Other Chronic Conditions

Pharmacy Times

Adalimumab-aacf (Idacio) is indicated for chronic conditions such as rheumatoid arthritis, plaque psoriasis, ulcerative colitis, psoriatic arthritis, hidradenitis suppurativa, and juvenile idiopathic arthritis.

FDA 122
article thumbnail

Opinion: The art of the ‘deceased note’: A physician grapples with documenting patients’ final moments

STAT

My grandmother died in the hospital, alone, the day after she was “found down” at home by emergency medical services. I lived near my Nani, as I called her but, even though I am a physician, was not allowed to see her after she had been admitted to her local hospital because of the strict, Covid-related no-visitor policy. I spent most of the evening sitting in my car in the hospital parking lot, paralyzed.

article thumbnail

Keytruda, mRNA Combination Cancer Vaccine Meets Primary Endpoint in Phase 2 Trial

Pharmacy Times

Merck and Moderna’s adjuvant melanoma treatment shows reduced risk of recurrence or death by 44% compared with pembrolizumab alone.

Vaccines 139
article thumbnail

A New Dimension in New Drug Molecules Research with Nanome’s VR technology [Interview]

Pharma Mirror

The COVID-19 pandemic challenged researchers to discover life-saving treatments at an unprecedented pace. While these researchers rose to the occasion by discovering drugs faster than ever before, variants continue to challenge the world in addressing COVID-19. New innovations in computer-aided drug discovery tools could dramatically accelerate the study of new variants.

105
105
article thumbnail

What the FDA's New Dosage Guidance Means for the Future of Clinical Research

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

article thumbnail

Expert: Pharmacists Should Be Aware of Indications for Various Types of Ovarian Cancer

Pharmacy Times

Clinical oncology pharmacist Amy Indorf, PharmD, BCOP, discusses her presentation on the role of PARP inhibitors for ovarian cancer.

123
123
article thumbnail

Early flu season in U.S. may be peaking early, too

STAT

This year’s abnormally early flu season is showing signs it may be peaking in parts of the country, data the Centers for Disease Control and Prevention released on Friday suggested. The percentage of outpatient visits to health care providers that were for respiratory illnesses declined for a second week in a row, CDC’s weekly influenza report, FluView , showed.

Hospitals 104
article thumbnail

A Study of Immune Checkpoint Inhibitors and Complication Rates

Drug Topics

Immune checkpoint inhibitor therapy does not appear to increase complication rates in patients undergoing dermatologic procedures.

article thumbnail

2023 forecast: 7 immediate and long-term priorities for hospital leaders

Fierce Healthcare

2023 forecast: 7 immediate and long-term priorities for hospital leaders. dmuoio. Fri, 12/16/2022 - 18:10.

Hospitals 131
article thumbnail

5 Reasons to Upgrade Your Pharmacy Management Software

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

article thumbnail

Studies indicate updated Covid boosters effective at reducing need for medical care

STAT

Researchers at the Centers for Disease Control and Prevention released data Friday indicating that the newer two-strain Covid booster shots provide substantial protection against illness and hospitalization, even in the previously vaccinated. The Food and Drug Administration said Friday that it will convene an advisory hearing next month to discuss what vaccines should look like going forward, including whether people who have never received any Covid vaccines should receive the bivalent as thei

article thumbnail

Top Blog Posts of 2022 – 6 Pillars Of Pharmacy Profit – Cash-Based Revenue

DiversifyRx

2022 was another crazy year for independent pharmacies. Lots of ups and downs. To ensure you didn’t miss a critical idea, we are recapping our most popular blogs for each Pharmacy Profit Pillar. It can be challenging to stay up-to-date with the always-evolving world of pharmacy as you try to integrate new methods of doing things to succeed. The KEY to growing your pharmacy profit is implementing tactics within each of the 6 pillars of profitability.

article thumbnail

Ten ways to ‘silent-night’ in peace

pharmaphorum

Oliver Stohlmann’s Corporate Survival Hacks series draws on his experiences of working in local, regional, and global life science communications to offer some little tips for enjoying a big business career. In this year-end column, he reflects on measures to ensure your festive break becomes that – festive, and a proper break – and that you’re not burning through precious off-time without any relaxation.

article thumbnail

STAT+: Pharmalittle: AbbVie leaves pharma industry trade groups; net drug prices see big drop after inflation

STAT

And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, you may recall, our treasured signal to daydream about weekend plans. Our agenda is quickly filling up. Besides the usual promenading with the official mascot, we plan to hang with at least two of our short people, one of whom returns from an institution of higher learning.

98
article thumbnail

The Pandemic Treaty and the opportunity to end ‘vaccine apartheid’

pharmaphorum

Ben Hargreaves discovers why some have referred to the distribution of COVID-19 vaccines and treatments as a form of apartheid. Further, with a pandemic treaty in development, there are reasons to believe that many countries and the WHO want to see a more equitable distribution of medical products for future pandemics. The world was caught unprepared for the global pandemic that struck in 2020.

article thumbnail

Hypermobile Joints Linked with Heightened Risk for Depression, Anxiety in Adolescents

Pharmacy Times

The study also found that joint hypermobility was more common in females than in males.

123
123
article thumbnail

Can pharma quit Twitter? Social strategy evolves as Musk changes the platform

PharmaVoice

A breakdown of how Twitter’s recent shifts are impacting pharma, and how the industry should navigate the platform in 2023.

106
106
article thumbnail

Industry Voices—Innovative mental healthcare practices are hampered by access challenges, administrative burdens

Fierce Healthcare

Industry Voices—Innovative mental healthcare practices are hampered by access challenges, administrative burdens. hlandi. Fri, 12/16/2022 - 08:14.

98
article thumbnail

Evaluating Chronic Itch and Quality of Life

Drug Topics

Several factors predict itch-specific quality of life in patients with chronic itch.

98
article thumbnail

STAT+: Up and down the ladder: The latest comings and goings

STAT

Hired someone new and exciting? Promoted a rising star? Finally solved that hard-to-fill spot? Share the news with us, and we’ll share it with others.  That’s right. Send us your changes, and we’ll find a home for them. Don’t be shy. Everyone wants to know who is coming and going. And here is our regular feature in which we highlight a different person each week.

97
article thumbnail

Walgreens Finds Care partners with Music Health to offer music app for dementia patients

Drug Store News

The new app is designed to temporarily improves patients’ quality of life and helps caregivers deliver more effective care with ease.

98
article thumbnail

WHO updates guidelines for treating drug-resistant tuberculosis

European Pharmaceutical Review

The World Health Organization (WHO) has released its updated consolidated guidelines on treatment for drug-resistant tuberculosis (DR-TB), which features major improvements in treatment options for people with multidrug-resistant or rifampicin-resistant tuberculosis (MDR/RR-TB), including a regimen that offer better patient outcomes. The 2022 updates include a new recommendation on the use of a novel all-oral six-month regimen made up of bedaquiline, pretomanid, linezolid and moxifloxacin (BPaLM

article thumbnail

Study Finds RAS Inhibition Has Little Effect on Outcomes in Advanced Chronic Kidney Disease

Pharmacy Times

A randomized study of renin-angiotensin system inhibitors in advanced chronic kidney disease found that patients who continued receiving therapy had similar outcomes to those who discontinued treatment.

73
article thumbnail

Long COVID Lingers While Patients, Physicians Want Pandemic to End

Drug Topics

A physical medicine specialist describes her experience as a doctor and as a patient, and explains why primary care will be the center for treatment.

76
article thumbnail

How nurturing relationships with skin care professionals builds retail sales and credibility

Drug Store News

Dermatology and Retail Alliance meets in Austin, Texas, to discuss strategies for improving patients’ skin care outcomes.

98
article thumbnail

After prior rejection, Ferring finally nabs FDA nod for bladder cancer gene therapy

Fierce Pharma

After prior rejection, Ferring finally nabs FDA nod for bladder cancer gene therapy. esagonowsky. Fri, 12/16/2022 - 15:19.

FDA 98
article thumbnail

Alzheimer’s therapeutics market to reach $6.8 billion by 2032

European Pharmaceutical Review

According to a report by Future Market Insights (FMI), the global Alzheimer’s therapeutics market is expected to grow at a compound annual growth rate (CAGR) of 9.3 percent, and driven largely by collaboration of existing players, reach $6.8 billion by 2032. The report predicted the Alzheimer’s therapeutics market will reach $2.8 billion worldwide in 2022.

article thumbnail

Centene expects to earn at least $137.4B in revenue for 2023

Fierce Healthcare

Centene expects to earn at least $137.4B in revenue for 2023. pminemyer. Fri, 12/16/2022 - 16:16.

106
106
article thumbnail

Anumana and Pfizer team up on AI-enabled ECG algorithm for detection of cardiovascular disease

Pharmafile

Anumana, an AI-driven health technology firm, has signed a multi-year deal with Pfizer in order to develop an AI electrocardiogram (AI-ECG) for the early detection of cardiac amyloidosis. Anumana will conduct a clinical validation trial in order to pursue De Novo classification for the algorithm as a Software-as-a-Medical-Device (SaMD), with the aim to gain regulatory approval in the US, Europe and Japan. read more.

article thumbnail

News Roundup: December 12 to December 16

Drug Topics

Your weekly roundup of the latest news from Drug Topics®.

98